Site #1 is a clinical research site located in San Diego, California, United States 92123.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Site #1 has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Tinea Cruris, Tinea Pedis, Netherton Syndrome.
Sponsors: Therapeutics, Inc., Quoin Pharmaceuticals.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site #1 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site #1 has 3 clinical trials on record, with 2 currently active. Their work covers Tinea Cruris, Tinea Pedis, Netherton Syndrome.
Site #1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.